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Occupational exposure in ANCA-positive patients: A case-
control study.
Background. Antineutrophil cytoplasmic autoantibodies
(ANCA) are valuable biomarkers for the diagnosis and follow-
up of small vessel vasculitis. The role of ANCA has not yet
been fully established, but genetic, infectious, and/or environ-
mental factors may increase susceptibility to these diseases. We
performed an epidemiologic study to investigate whether the
presence of ANCA was associated with silica or any other form
of occupational exposure, regardless of the underlying disease.
Methods. All consecutive ANCA-positive patients recorded
at the institution’s Laboratory of Immunology between 1990
and 2000 were included. Patients hospitalized in a unit of in-
ternal medicine matched for age and gender were selected as
controls (two controls/case). Qualitative and semiquantitative
professional exposure and smoking habits were analyzed by five
experts blind to the diagnosis.
Results. Univariate analysis showed that patients who re-
ported dust exposure had a 2.6 greater risk of being ANCA-
positive (P = 0.007) (odds ratio 2.6; 95% CI 1.3 to 5.3) and
individuals with professional exposure to silica had a 3.4 higher
risk of being ANCA-positive (P = 0.03) (odds ratio 3.4; 95% CI
1.1 to 9.9). None of the other environmental factors or smok-
ing habits were different between ANCA-positive patients and
controls. There was no difference in silica exposure between pa-
tients with cytoplasmic ANCA (c-ANCA), perinuclear ANCA
(p-ANCA), or atypical ANCA.
Semiquantitative analysis showed a dose effect of silica ex-
posure with a nearly sevenfold greater risk of being ANCA-
positive compared to controls (P = 0.02) (odds ratio 6.9; 95%
CI 1.3 to 35.1).
Conclusion. These results support the hypothesis that the
presence of ANCA in plasma might at least partially be related
to occupational exposure.
Key words: antineutrophil cytoplasmic antibodies, occupational expo-
sure, silica, case-control study.
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Antineutrophil cytoplasmic autoantibodies (ANCA)
are frequently associated with small vessel vasculitis
such as Wegener granulomatosis, Churg and Strauss
syndrome, microscopic polyangiitis, pauci-immune
glomerulonephritis, and Goodpasture syndrome [1].
ANCA serve as biomarkers for the diagnosis and
follow-up of these diseases but they are also detected in
the serum of patients suffering from other diseases such
as autoimmune rheumatism [2], chronic inflammatory
intestinal disease [3], Sjogren syndrome [4], autoimmune
hepatitis [5], and lupus [6]. Antithyroid drug-induced
ANCA-associated vasculitis has also been reported [7].
ANCA are biomarkers which are detected on indi-
rect immunofluorescence assay and three different types
of fluorescence have been identified [i.e., cytoplasmic
ANCA (c-ANCA), perinuclear ANCA (p-ANCA), and
atypical ANCA] [8, 9]. The cytoplasmic antigen targets
of each of these antibodies are different. c-ANCA are
mostly associated with antiproteinase 3 (PR3) antibod-
ies whereas p-ANCA are associated with antimyeloper-
oxidase (MPO) antibodies. Wegener granulomatosis is
predominantly associated with c-ANCA (75%), while
microscopic polyangiitis, Churg and Strauss syndrome,
pauci-immune glomerulonephritis, and Goodpasture
syndrome are predominantly associated with p-ANCA
(50%, 60%, 70%, and 25%, respectively) [9].The antigen
specificity of atypical ANCA is less clearly defined [9].
The precise role of ANCA in ANCA-associated dis-
eases has not yet been clearly established [10, 11]. Some
studies using animal models have suggested that the
anti-MPO antibody would alone be capable of creating
necrotizing glomerulonephritis [12]. MPO knockout mice
immunized with murine MPO developed an anti-MPO
antibody response. Small vessel vasculitis and necrotiz-
ing and crescentic glomerulonephritis developed when
splenocytes from these animals were transplanted to
RAG2 mice [11].
Certain factors, particularly the genetic, infectious and
environmental factors, may influence the occurrence of
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such diseases. Indeed an association between severe and
moderate protease inhibitor-deficient phenotypes and
ANCA-positive vasculitis has been described [13] and
cotrimoxazole has been reported to prevent relapses of
vasculitis [14].
Environmental factors, particularly silica exposure,
have been reported to be associated with certain forms of
ANCA-associated vasculitis [15, 16] and with several au-
toimmune diseases such as scleroderma [17], rhumatoid
arthritis [18, 19], dermatomyositis [8], and lupus [6].
The aim of this study was to determine whether the
presence of ANCA in plasma is associated with silica ex-
posure regardless of the underlying disease. As this study
was performed through a panel of experts, we analyzed
any occupational exposure to toxic agents in these sub-
jects.
METHODS
Detection of ANCA
All ANCA were detected in serum by indirect im-
munofluorescence in the same laboratory according to
the standard procedure established at the first ANCA
workshop [20]. Positive indirect immunofluorescence was
classified as c-ANCA, p-ANCA, or atypical ANCA (In-
ova, San Diego, CA, USA). Sera positive for p-ANCA
or atypical ANCA were also tested for antinuclear activ-
ity on Hep 2 cells. Antigen target specificity of ANCA
for PR3 or MPO was systematically investigated us-
ing a commercially available enzyme-linked immunoab-
sorbent assay (ELISA) (Pharmacia, Freiburg, Germany)
since 1996.
Selection of ANCA patients and controls
All patients admitted to the Tours University Hospital
between 1990 and 2000 with the first known serum ANCA
levels at a dilution rate of at least 1/20 were included,
regardless of specificity and/or the underlying disease.
A total of 97 patients were ANCA-positive during the
study period. Thirty-seven patients were excluded from
the study for loss to follow-up (N = 13) (13.4%), refusal
to participate (N = 6) (6.2%), death (N = 18) (18.6%),
leaving a total of 60 patients (Fig. 1).
The diseases which were diagnosed in the 60 ANCA-
positive patients included Wegener granulomatosis ac-
cording to the 1990 American College of Rheumatology
(N = 20) [21], microscopic polyangiitis (N = 8), pauci-
immune glomerulonephritis (N = 10), and uveitis (N =
6), and also Horton disease (N = 2) and stroke (N = 4)
(Table 1).
Control subjects were selected from patients admitted
to the Department of Internal Medicine in the same hos-
pital between 2000 and 2001 and matched with ANCA-
positive patients on the basis of age (within 5 years)
Table 1. Diseases in 60 antineutrophil cytoplasmic autoantibodies
(ANCA)-positive patients
Cytoplasmic Perinuclear Atypical
ANCA ANCA ANCA Total
Disease N = 20 N = 29 N = 11 N = 60
Wegener disease 13 7 0 20
Pauci-immune 0 7 3 10
glomerulonephritis
Microscopic 1 6 1 8
polyangiitis
Uveitis 3 1 2 6
Churg and Strauss 0 3 1 4
syndrome
Stroke 2 1 1 4
Horton disease 0 2 0 2
Periarteritis nodosa 1 1 0 2
Circulating 0 1 0 1
anticoagulant
Autoimmune hepatitis 0 0 1 1
Rheumatoid arthritis 0 0 1 1
Hemorrhagic 0 0 1 1
rectocolitis
and gender. Two control subjects were selected for each
ANCA-positive patient. All control subjects were tested
for ANCA in the same laboratory and all were confirmed
to be negative. Controls were in-patients with diabetes
(N = 76), cardiovascular diseases (N = 25), or miscel-
laneous other diagnosis (N = 19). Patients treated with
neomercazole or suffering from infectious diseases (par-
ticularly endocarditis), antiphospholipid antibodies, or
malignancies were excluded from the study to avoid pa-
tients with false positive titers with ANCA.
Exposure
Occupational exposure was evaluated by a standard
interviewer-administered questionnaire. The structured
questionnaire consisted of questions on life style such
as smoking and on work. For each job lasting for pe-
riods longer than 6 months, job status, company name,
years worked, detailed description of tasks performed
and working environment, including information regard-
ing dust and exposure (silica dust, silicon, organic solvent,
and any other known toxic agent), were reported. A panel
of five experts blind to the diagnosis (three occupational
physicians, one epidemiologist, and one industrial hygien-
ist) studied the responses questionnaires for each patient
together. Analysis of occupational exposure was both
qualitative and semiquantitative. An exposure score was
calculated for each person’s employment periods during
which exposure to each toxic agent occurred. This expo-
sure score took into account the probability of exposure
(probability score of 0, nonexposure; 0.25, possible expo-
sure; 0.75, probable exposure; and 1, certain exposure),
intensity of exposure (intensity score from 0 for nonex-
posure to 4 for highest level of exposure), frequency of
exposure (with a frequency score based on length of time
worked daily <10%, 0.05; 10% to 50%, 0.30; and >50%,
Beaudreuil et al: Occupational exposure in ANCA-positive patients 1963
ANCA patients
N = 60
c-ANCA
N = 20 (33.3%)
p-ANCA
N = 28 (46.7%)
Atypical-ANCA
N = 12 (20%)
Anti-MPO N = 2 (10%)
Anti-PR3 N = 12 (60%)
Undetermined N = 6 (30%)
Anti-MPO N = 20 (71.4%)
Anti-PR3 N = 1 (3.6%)
Undetermined N = 7 (25%)
Anti-MPO N = 0 (0%)
Anti-PR3 N = 0 (0%)
Undetermined N = 12 (100%)
Fig. 1. Patients enrolled in the study, with type and specificity of antineutrophil cytoplasic antibodies (ANCA). Abbreviations are: anti-MPO,
antimyeloperoxidase antibodies; anti-PR3, antiproteinase 3 antibodies; c-ANCA, cytoplasmic ANCA; p-ANCA, perinuclear ANCA.
0.75) and duration of exposure (number of years worked).
Finally, the exposure score for each employment period
was expressed as the product of probability × intensity
× frequency × duration. The final cumulative exposure
score for each subject was expressed as the sum of [17,
22] employment exposure scores, taking into account all
periods of employment. Four increasing degrees of occu-
pational exposure score were defined: nil, low (score <2),
moderate (2 to 4), and high (score >4). Exposure peri-
ods that were considered for statistical analysis of cases
and controls were the same and preceded the diagnosis
of diseases.
Statistical analysis
Conditional logistic analysis was performed to estimate
the relation between the different variables by univaraite
and multivariate analysis. Maximum likelihood were es-
timated using odds ratio (OR) and confidence intervals
(95% CI).The Armitage trend test was used to evaluate
whether there was a dose and effect relationship between
the cumulative silica exposure and the presence of the
biomarker ANCA [23]. A value of P ≤ 0.05 was consid-
ered statistically significant.
RESULTS
Baseline characteristics
A total of 180 patients responded, of whom 60 were
ANCA-positive (cases) and 120 were control subjects
(controls). As expected, age and gender were compara-
ble between ANCA-positive patients and control sub-
jects (mean ± SD 61.2 ± 12.5 years vs. 61.8 ± 12.6 years
and 30 males/30 females vs. 60 males/60 females, respec-
tively). All cases and controls lived within 200 km of the
hospital.
Occupational exposure
Self reported. ANCA-positive patients reported sig-
nificantly more frequent exposure to dusty environments
during their working lives than control subjects (OR =
2.6; 95% CI 1.3 to 5.3) (P = 0.007). There was no dif-
ference between the two groups for recent or previous
smoking history (Table 2).
Qualitative analysis. Qualitative analysis of work ex-
posure by the panel of experts showed that ANCA-
positive patients were significantly more often exposed
to silica than the control subjects (OR = 3.4; 95% CI 1.1
to 9.9) (P = 0.03). Twenty-five percent of the c-ANCA-
positive patients (N = 5), 21% of the p-ANCA-positive
patients (N = 6) and 17% of the atypical ANCA-positive
patients were exposed to silica (P = 0.34). There was no
significant difference between ANCA-positive patients
and control subjects in the exposure to any other toxins
evaluated by the experts, in particular to white spirit, sil-
icone, benzene, paint, or lead (Table 3). There was also
no significant difference between groups on pooling chlo-
rate solvents (trichlorethylene, trichlorethan, and tetra-
chlorethylene) (OR 1.5; 95% CI 0.7 to 3.1) (P = 0.30),
aromatic solvents (benzene, toluene, and xylene) (OR
1.4; 95% CI 0.6 to 3.2) (P = 0.46), and all solvents to-
gether (OR 1.6; 95% CI 0.8 to 3.2) (P = 0.22).
Quantitative analysis. Quantitative analysis showed a
dose-effect relationship between silica exposure and the
ANCA biomarker. When four groups of silica exposure
of increasing intensity were defined the OR increased
with intensity of silica exposure (trend test P < 0.01)
(Table 4). The OR was statistically significant for high
silica exposure (OR = 6.9; 95% CI 1.3 to 35.1) (P < 0.01).
Delay and type of silica exposure. In exposed pa-
tients to silica, duration of silica exposure was 16.3 years
(± 12.5) for ANCA-positive patients (N = 13) compared
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Table 2. Qualitative analysis of self-reported smoking and self-reported occupational dust exposure in antineutrophil cytoplasmic autoantibodies
(ANCA)-positive patients and matched controls
ANCA patients Controls Odds ratio
N = 60 N = 120 (95% CI) P value
Smoking
Nonsmoker (%) 34 (56.6) 68 (56.7) 1
Previous (%) 7 (11.7) 23 (19.2) 0.6 (0.2–1.6) 0.4
Current (%) 19 (31.7) 29 (24.1) 1.3 (0.6–2.7)
Occupational dust exposure (%) 29 (48.3) 34 (28.3) 2.6 (1.3–5.3) 0.007
Table 3. Risk associated with occupational exposure in 60 antineutrophil cytoplasmic autoantibodies (ANCA)-positive patients and 120 matched
controls evaluated blind by five experts
ANCA patients Controls Odds ratio
Toxics number (%) Number (%) (95% CI) P value
Silica 13 (21.7) 13 (10.8) 3.4 (1.1–9.9) 0.03
Silicone 10 (16.7) 19 (15.8) 1.1 (0.4–2.9) 0.87
Toluene 4 (6.7) 11 (9.1) 0.6 (0.2–2.4) 0.52
Trichlorethylene 11 (18.3) 21 (17.5) 1.1 (0.5–2.4) 0.89
White spirit 14 (23.3) 18 (15) 1.9 (0.8–4.3) 0.15
Benzene 7 (11.7) 12 (10) 1.2 (0.4–3.2) 0.73
Tetrachlorethylene 5 (8.3) 5 (4.1) 2.0 (0.6–6.9) 0.27
Trichlorethane 4 (6.7) 1 (0.8) 8.0 (0.9–71.6) 0.06
N hexane 2 (3.3) 5 (4.1) 0.2 (0.1–4.5) 0.77
Epoxy resin 7 (11.7) 9 (7.5) 1.9 (0.6–6.5) 0.29
Pesticide/herbicide 10 (16.7) 16 (13.3) 1.33 (0.553.07) 0.54
Solder 8 (13.3) 13 (10.8) 1.3 (0.5–3.7) 0.60
Asbestos 9 (15) 15 (12.5) 1.3 (0.5–3.2) 0.63
Petrol 11 (18.3) 18 (15) 1.3 (0.5–3.1) 0.55
Oil 11 (18.3) 21 (17.5) 1.3 (0.5–3.1) 0.88
Xylene 6 (10) 11 (9.2) 1.1 (0.5–2.5) 0.84
Formalin 6 (10) 6 (5) 2.2 (0.6–7.2) 0.21
Glue 4 (6.7) 13 (10.3) 0.6 (0.2–1.9) 0.38
Paint 2 (3.3) 6 (5) 0.6 (10−4–3.5) 0.57
Glycol ether 6 (10) 9 (7.5) 1.4 (0.5–4.0) 0.57
Lead 3 (5) 9 (7.5) 0.6 (0.2–2.5) 0.50
Vegetable dust 6 (10) 18 (15) 0.6 (0.2–1.7) 0.36
Aromatic amine 4 (6.7) 2 (1.7) 4.0 (0.7–21.8) 0.11
Carbon oxide 1 (1.7) 2 (1.7) 1.0 (10−7–11.0) 1
Maximum likelihood estimate of the odds ratio (OR) and confidence intervals (95% CI).
Table 4. Risk associated with final high, moderate, low or nil
cumulative silica exposure score in patients with antineutrophil
cytoplasmic antibodies (ANCA) and matched controls
ANCA patients Controls Odds ratio
Score number (%) number (%) (95% CI) P value
Nil 47 (78.3) 107 (89.1) 1
Low 2 (3.3) 6 (5) 0.8 (0.15–3.9) 0.74
Moderate 5 (8.3) 5 (4.2) 2.3 (0.63–8.24) 0.20
High 6 (10) 2 (1.6) 6.9 (1.33–35.09) 0.002
Maximum likelihood estimated using odds ratio (OR) and confidence intervals
(95% CI).
Trend test P = 0.009.
to 19.4 years (±15.7) in control subjects (N = 13). The
jobs associated with silica exposure in ANCA-positive
patients were bricklaying (N = 7), foundry work (N = 3),
laying tiles (N = 2), and there was one coal merchant,
whereas control subjects included bricklayers (N = 5,
dental prosthetist (N = 1), brick makers (N = 5) and
those who lay tiles (N = 2). The interval between the be-
ginning of silica exposure and discovery of ANCA was
36.3 years ±13.7 years (mean ± SD). The interval be-
tween the end of silica exposure and discovery of ANCA
was 19.5 ± 19.5 years (mean ± SD).
DISCUSSION
We sought to determine whether the presence of
ANCA is associated with work exposure, regardless of
the underlying disease. The incidence of ANCA in the
general population has not yet been fully established and
might be influenced by geographic factors [24]. A case-
control study was therefore designed in view of the low
prevalence of this biomarker [25], which is an epidemi-
ologic tool to reveal disease etiology [26] in the general
population.
Several studies have been conducted to evaluate the
risk of occupational exposure and vasculitis, whether as-
sociated with ANCA or not. An association between
rapidly progressive ANCA-positive glomerulonephritis
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and exposure to silica dust was studied in 16 patients and
compared to 32 controls [27]. The authors reported a 14-
fold greater risk of glomerulonephritis in silica-exposed
patients. Of the seven patients who reported a history
of work exposure to silica dust and who suffered from
acute nephritis, six were p-ANCA-positive and one had
no ANCA. In a case-control study, Nuyts et al [28] evalu-
ated the role of occupational exposure in the occurrence
of Wegener granulomatosis with renal involvement.
Sixteen patients (13 c-ANCA-positive and three un-
determined) were compared with 32 age- and gender-
matched controls. Occupational exposure was scored by
an industrial hygienist. Inhalation of silicon-containing
compounds such as silica was associated with a nearly
sevenfold risk of Wegener glomerulomatosis [28],
whereas exposure to lead or cadmium was not associ-
ated with this disease. As in the present study the authors
described considerable variability between the beginning
of exposure to silica and the occurrence of disease.
Occupational exposure was recently compared be-
tween 101 patients suffering from Wegener glomerulo-
matosis and 123 controls, including 54 healthy controls,
24 patients with sarcoidosis or idiopathic pulmonary fi-
brosis, and 45 patients with inflammatory rheumatism.
Patients with Wegener glomerulomatosis were signifi-
cantly more often exposed to grain dust or fumes than
controls (P < 0.001) but the presence of ANCA was not
reported [15]. Finally, professional exposure was com-
pared between 65 patients with ANCA vasculitis (34 with
c-ANCA and 31 with p-ANCA) and 65 healthy controls
in a multicenter study. The OR of silica dust exposure was
4.4 times greater for patients with ANCA vasculitis com-
pared to control subjects [16]. However, in this study the
testing for ANCA and MPO and PR3 specificity were
performed in several centers, whereas in our study all
analyses were performed at the same institution. Indeed
standardization of ANCA testing between different lab-
oratories is necessary to avoid misinterpretation of re-
sults [29]. Interestingly, as in our study, there was no
association between smoking habits and ANCA-
associated disease. Finally, the impact of environmental
factors was reported in 75 patients suffering from pri-
mary systemic vasculitis (58 with ANCA and 17 without
ANCA) in a case-control study [30]. A significant associ-
ation between farming and vasculitis was identified.
The present study showed a significant association be-
tween silica and the presence of ANCA. This is the first
study to our knowledge that demonstrates an associa-
tion between a biomarker of autoimmune disease and
silica exposure. There was no difference between speci-
ficity of ANCA and silica exposure. The way silica expo-
sure might influence the occurrence of ANCA has not yet
been clearly established. ANCA-related vasculitis might
be related to a disease process in which accelerated apop-
tosis of polynuclear neutrophils and macrophages may
act as a trigger [31]. Accelerated apoptosis has been in-
duced through intratracheal instillation of silica in Wistar
rats in a dose-dependent manner [32]. Moreover, in vitro
studies have shown that silica may induce apoptosis in
human peripheral blood lymphocytes, with an increase
in Fas-mediated cell death after stimulation with silicate
[33].
The predominant role of silica in the association with
ANCA is confirmed by the fact that none of the other
components studied was significantly different between
patients and controls. Despite a very wide range of prod-
ucts examined blind by five experts, no other association
between exposure and the ANCA biomarker was ob-
served, even when solvents were considered as a group.
The fact that self-reported dust exposure was significantly
associated with ANCA might be explained through the
high percentage of silica contained in dust.
Silica is widely used in many industries, including min-
ing and quarrying (metallic and nonmetallic minerals),
stone cutting, construction activities (tunnels and build-
ings) and sandblasting [34]. It is of note that seven out
of 13 patients exposed to silica associated with ANCA-
related disease in our study worked as bricklayers. In a
previous study of occupational exposure to silica in indi-
viduals suffering from Wegener glomerulomatosis, three
out of four patients exposed to silica were bricklayers
[22]. This might thus be an occupational category at high
risk of ANCA-related disease.
To evaluate the dose of silica on the incidence of ANCA
we performed a quantitative analysis of the exposure.
We observed a positive dose-effect relationship between
silica exposure and the presence of ANCA, particularly
concerning the intensity of exposure. This is in accordance
with a previous study where a high silica exposure index
was associated with an increased risk of primary vasculitis
[30]. Accelerated apoptosis of macrophages or polynu-
clear neutrophils might thus be a dose-dependent effect.
The reasons why some individuals develop ANCA
after silica exposure, and others do not, remain to be
resolved. Genetic and/or infectious factors could play a
crucial role.
In the present case-control study we evaluated the risk
of occupational exposure in patients with a measurable
marker, and not with a clinical entity which may be diffi-
cult to define. ANCA-positive patients and controls were
recruited in the same hospital, thus limiting the risk of
bias through control selection and nearly all patients and
controls lived within a distance of 200 km from this hos-
pital. The exclusion of 37 patients because of death or
loss to follow-up may have introduced a bias. However,
it is more likely that the drop-out of these patients would
underestimate than overestimate the OR of the role of
occupational exposure in this study.
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CONCLUSION
Our study confirmed that environmental factors may
be associated with the occurrence of autoimmune dis-
eases. Occupational exposure, in particular to silica,
might thus play a key role in the pathogenesis of oc-
currence and/or relapse of ANCA-related diseases and
should be systematically explored in patients with such
diseases.
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